ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
Public ClinicalTrials.gov record NCT03759340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open label study of ATI-502 Topical Solution for the treatment of AA, AU, and AT with the following goals: * To assess the safety, tolerability, and efficacy of ATI-502 Topical Solution in subjects with AA, AU or AT following 24 weeks of treatment with ATI-501 Oral Suspension or Placebo Suspension. * To assess the ability of ATI-502 Topical Solution to maintain or improve hair regrowth in subjects previously treated with ATI-501 Oral Suspension or Placebo Suspension.
Study identification
- NCT ID
- NCT03759340
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 56 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 15, 2019 (Actual)
- Primary completion
- Sep 11, 2019 (Actual)
- Completion
- Sep 11, 2019 (Actual)
- Last update posted
- Oct 6, 2020
2019
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aclaris Investigator Site | Rogers | Arkansas | 72758 | — |
| Aclaris Investigator Site | Denver | Colorado | 80210 | — |
| Aclaris Investigator Site | Boynton Beach | Florida | 33472 | — |
| Aclaris Investigator Site | Snellville | Georgia | 30078 | — |
| Aclaris Investigator Site | Clinton Township | Michigan | 48038 | — |
| Aclaris Investigator SIte | Detroit | Michigan | 48202 | — |
| Aclaris Investigator Site | Fridley | Minnesota | 55432 | — |
| Aclaris Investigator Site | Minneapolis | Minnesota | 55455 | — |
| Aclaris Investigator Site | Saint Joseph | Missouri | 64506 | — |
| Aclaris Investigator Site | Omaha | Nebraska | 68144 | — |
| Aclaris Investigator Site | Las Vegas | Nevada | 89148 | — |
| Aclaris Investigator Site | New York | New York | 10075 | — |
| Aclaris Investigator Site | Rochester | New York | 14623 | — |
| Aclaris Investigator Site | Portland | Oregon | 97223 | — |
| Aclaris Investigator Site | Greenville | South Carolina | 29607 | — |
| Aclaris Investigator Site | Knoxville | Tennessee | 37922 | — |
| Aclaris Investigational Site | Nashville | Tennessee | 37215 | — |
| Aclaris Investigational Site | Austin | Texas | 78745 | — |
| Aclaris Investigator Site | Houston | Texas | 77056 | — |
| Aclaris Investigator Site | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03759340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03759340 live on ClinicalTrials.gov.